The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The safety, tolerability and efficacy of LP-10 in subjects with refractory moderate to severe hemorrhagic cystitis: Phase 2a multicenter dose escalation clinical trial.
 
Michael Chancellor
Employment - Lipella Pharmaceuticals, Inc.
Leadership - Lipella Pharmaceuticals, Inc.
Stock and Other Ownership Interests - Lipella Pharmaceuticals, Inc.
Patents, Royalties, Other Intellectual Property - Lipella Pharmaceuticals, Inc.
 
Benjamin Breyer
Research Funding - Lipella Pharmaceuticals, Inc.
 
Shreyas S. Joshi
Research Funding - Lipella Pharmaceuticals, Inc.
 
Christopher Smith
Research Funding - Lipella Pharmaceuticals, Inc.
 
Melissa Kaufman
Research Funding - Lipella Pharmaceuticals, Inc.
 
Janet Okonski
Employment - Lipella Pharmaceuticals, Inc.
 
Jason Hafron
Employment - Michigan Institute of Urology
Honoraria - Amgen; Astellas Pharma; Bayer; Blue Earth Diagnostics; Dendreon; Janssen Biotech; Lantheus Medical Imaging; Merck; Myovant Sciences; Myriad Genetics; Pfizer; Procept Biorobotics; Tolmar; Urogen pharma
Consulting or Advisory Role - Astellas Pharma; Dendreon; Janssen Biotech; Lilly; LynxDx; Myovant Sciences; Myriad Genetics; Pfizer; Promaxo
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Blue Earth Diagnostics; Dendreon; Janssen Biotech; Myovant Sciences; Myriad Genetics; Pfizer; Procept Biorobotics; Tolmar; Urogen pharma
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Dendreon (Inst); Janssen Biotech (Inst); Lipella Pharmaceuticals (Inst); Merck (Inst); miR Scientific (Inst); Myovant Sciences (Inst); Myriad Genetics (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Dendreon; Janssen Biotech; Merck; Myovant Sciences; Pfizer; Tolmar; Urogen pharma